Nerve Growth Factor–Induced Sensitization of the Sternocleidomastoid Muscle and Its Effects on Trigeminal Muscle Sensitivity and Pain Profiles: A Randomized Double-Blind Controlled Study

Aims: To investigate whether localized sensitization of the sternocleidomastoid (SCM) muscle using nerve growth factor (NGF) would affect masseter and anterior temporalis muscle sensitivity and pain profiles. Methods: A total of 28 healthy participants attended two sessions (T0 and T1). At T0, the maximum voluntary occlusal bite force (MVOBF), as well as pressure pain thresholds (PPT), mechanical sensitivity, and referred pain/sensations for the SCM, masseter, and temporalis muscles, were assessed. Participants also completed the Pain Catastrophizing Scale (PCS), the Pain Vigilance and Awareness Questionnaire (PVAQ), and the Neck Disability Index (NDI). After these assessments, 14 participants received an injection of NGF into the SCM, and 14 received an injection of isotonic saline solution. At T1 (48 hours postinjection), the participants were again submitted to the same evaluations. Results: NGF caused significant mechanical sensitization in the SCM (P < .025), but not in the masseter or temporalis muscles (P > .208). It also caused significant increases in NDI score (P = .004). No statistically significant differences were found for MVOBF, frequency of referred pain/sensations, or questionnaire scores (P > .248). Conclusion: These results suggest that 48 hours after localized sensitization of the SCM, the primary response is impairment of neck function, but not jaw function.

behavior; masticatory muscles; musculoskeletal pain; neck pain; nerve growth factor

1. Christensen SW, Hirata RP, Graven-Nielsen T. Bilateral experimental neck pain reorganizes axioscapular muscle coordination and pain sensitivity. Eur J Pain 2017;21:681–691.

2. Sohn MK, Graven-Nielsen T, Arendt-Nielsen L, Svensson P. Effects of experimental muscle pain on mechanical properties of single motor units in human masseter. Clin Neurophysiol 2004; 115:76–84.

3. Svensson P, Wang K, Sessle BJ, Arendt-Nielsen L. Associations between pain and neuromuscular activity in the human jaw and neck muscles. Pain 2004;109:225–232.

4. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L. Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 2003;104:241–247.

5. Andersen H, Arendt-Nielsen L, Svensson P, Danneskiold- Samsøe B, Graven-Nielsen T. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans. Exp Brain Res 2008;191:371–382.

6. Mann MK, Dong XD, Svensson P, Cairns BE. Influence of intramuscular nerve growth factor injection on the response properties of rat masseter muscle afferent fibers. J Orofac Pain 2006;20:325–336.

7. Svensson P, Wang K, Arendt-Nielsen L, Cairns BE. Effects of NGF induced muscle sensitization on proprioception and nociception. Exp Brain Res 2008;189:1–10.

8. Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: A review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985;60:615–623.

9. Brodie AG. Anatomy and physiology of head and neck musculature. Am J Orthod 1950;36:831–844.

10. Hu JW, Sun KQ, Vernon H, Sessle BJ. Craniofacial inputs to upper cervical dorsal horn: Implications for somatosensory information processing. Brain Res 2005;1044:93–106.

11. Sessle BJ. Acute and chronic craniofacial pain: Brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 2000;11:57–91.

12. Serrao M, Rossi P, Parisi L, et al. Trigemino-cervical-spinal reflexes in humans. Clin Neurophysiol 2003;114:1697–1703.

13. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2013;310:2191–2194.

14. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

15. Vernon H. The Neck Disability Index: State-of-the-art, 1991– 2008. J Manipulative Physiol Ther 2008;31:491–502.

16. McCracken LM. “Attention” to pain in persons with chronic pain: A behavioral approach. Behav Ther 1997;28:271–284.

17. Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess 1995;7:524–532.

18. Sullivan MJL. The development of the Pain Catastrophizing Scale. Available at: http://sullivan painresearch.mcgill.ca/pcs. php. Accessed 11 August 2020.

19. Vernon H, Mior S. The Neck Disability Index: A study of reliability and validity. J Manipulative Physiol Ther 1991;14:409–415.

20. Suzuki S, Castrillon EE, Arima T, Kitagawa Y, Svensson P. Blood oxygenation of masseter muscle during sustained elevated muscle activity in healthy participants. J Oral Rehabil 2016;43:900–910.

21. Kazazoglu E, Heath MR, Müller F. A simple test for determination of the preferred chewing side. J Oral Rehabil 1994;21:723.

22. Álvarez-Méndez AM, Exposto FG, Castrillon EE, Svensson P. Systematic mapping of pressure pain thresholds of the masseter and temporalis muscles and assessment of their diversity through the novel application of entropy. J Oral Facial Pain Headache 2017;31:362–371.

23. Futarmal S, Kothari M, Ayesh E, Baad-Hansen L, Svensson P. New palpometer with implications for assessment of deep pain sensitivity. J Dent Res 2011;90:918–922.

24. Castrillon EE, Cairns BE, Wang K, Arendt-Nielsen L, Svensson P. Comparison of glutamate-evoked pain between the temporalis and masseter muscles in men and women. Pain 2012;153:823–829.

25. Ohrbach R. Diagnostic Criteria for Temporomandibular Disorders. Available at: www.rdc tmdinternational.org. Accessed 11 August 2020.

26. Masuda M, Iida T, Exposto FG, et al. Referred pain and sensations evoked by standardized palpation of the masseter muscle in healthy participants. J Oral Facial Pain Headache 2018;32:159–166.

27. Schmidt-Hansen PT, Svensson P, Jensen TS, Graven-Nielsen T, Bach FW. Patterns of experimentally induced pain in pericranial muscles. Cephalalgia 2006;26:568–577.

28. Cairns BE. Pathophysiology of TMD pain--basic mechanisms and their implications for pharmacotherapy. J Oral Rehabil 2010;37:391–410.

29. Wong H, Kang I, Dong XD, et al. NGF-induced mechanical sensitization of the masseter muscle is mediated through peripheral NMDA receptors. Neuroscience 2014;269:232–244.

30. Bennett DL. Neurotrophic factors: Important regulators of nociceptive function. Neuroscientist 2001;7:13–17.

31. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci. 1994;6:1903–1912.

32. Martinez-Calderon J, Jensen MP, Morales-Asencio JM, Luque- Suarez A. Pain catastrophizing and function in individuals with chronic musculoskeletal pain: A systematic review and meta- analysis. Clin J Pain 2019;35:279–293.

33. Roelofs J, Peters ML, McCracken L, Vlaeyen JW. The pain vigilance and awareness questionnaire (PVAQ): Further psychometric evaluation in fibromyalgia and other chronic pain syndromes. Pain 2003;101:299–306.

34. Katz J, Martin AL, Pagé MG, Calleri V. Alexithymia and fear of pain independently predict heat pain intensity ratings among undergraduate university students. Pain Res Manag 2009;14:299–305.

35. Kristiansen FL, Olesen AE, Brock C, et al. The role of pain catastrophizing in experimental pain perception. Pain Pract 2014;14:e136–e145.

36. Lautenbacher S, Huber C, Kunz M, et al. Hypervigilance as predictor of postoperative acute pain: Its predictive potency compared with experimental pain sensitivity, cortisol reactivity, and affective state. Clin J Pain 2009;25:92–100.

37. Keefe FJ, Rumble ME, Scipio CD, Giordano LA, Perri LM. Psychological aspects of persistent pain: Current state of the science. J Pain 2004;5:195–211.

38. Sampaio Bonafé FS, Marôco J, Duarte Bonini Campos JA. Cross cultural validation of the Brazilian Portuguese version of the Pain Vigilance and Awareness Questionnaire. J Oral Facial Pain Headache 2017;32:e1–e12.

39. Goiato MC, Zuim PRJ, Moreno A, et al. Does pain in the masseter and anterior temporal muscles influence maximal bite force? Arch Oral Biol 2017;83:1–6.

40. Shimada A, Baad-Hansen L, Svensson P. Effect of experimental jaw muscle pain on dynamic bite force during mastication. Arch Oral Biol 2015;60:256–266.

41. Peck CC, Murray GM, Gerzina TM. How does pain affect jaw muscle activity? The Integrated Pain Adaptation Model. Aust Dent J 2008;53:201–207.

42. Kumar A, Castrillon E, Svensson KG, et al. Effects of experimental craniofacial pain on fine jaw motor control: A placebo-controlled double-blinded study. Exp Brain Res 2015;233:1745–1759.

43. Testa M, Geri T, Gizzi L, Petzke F, Falla D. Alterations in masticatory muscle activation in people with persistent neck pain despite the absence of orofacial pain or temporomandibular disorders. J Oral Facial Pain Headache 2015;29:340–348.

44. Muñoz-García D, López-de-Uralde-Villanueva I, Beltrán- Alacreu H, La Touche R, Fernández-Carnero J. Patients with concomitant chronic neck pain and myofascial pain in masticatory muscles have more widespread pain and distal hyperalgesia than patients with only chronic neck pain. Pain Med 2017;18:526–537.